Elon Musk's Neuralink Receives FDA Clearance for Human Brain Implant Trial

Breaking News

Neuralink, the brain implant company founded by Elon Musk, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin human clinical trials of its first-in-human brain implant.

The implant, which includes 1024 electrodes distributed across 64 threads, is designed to let users control computers and mobile devices with their thoughts. It is the key hardware component of the trial, which will assess the safety and efficacy of the implant in people with paralysis or other neurological conditions.

In a statement, Neuralink said that the trial will initially involve a small number of participants who will be closely monitored. The company said it hopes to eventually expand the trial to include more participants and to test the implant in a wider range of applications.

The FDA's clearance is a major milestone for Neuralink, which has been working on the implant for several years. The company has said that it hopes to eventually develop the implant into a device that can be used to treat a variety of neurological conditions, including paralysis, blindness, and deafness.